Emily Sites

431 total citations
8 papers, 260 citations indexed

About

Emily Sites is a scholar working on Molecular Biology, Genetics and Genetics. According to data from OpenAlex, Emily Sites has authored 8 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 2 papers in Genetics. Recurrent topics in Emily Sites's work include Genomics and Rare Diseases (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Cancer-related Molecular Pathways (2 papers). Emily Sites is often cited by papers focused on Genomics and Rare Diseases (3 papers), Neurogenetic and Muscular Disorders Research (2 papers) and Cancer-related Molecular Pathways (2 papers). Emily Sites collaborates with scholars based in United States, Switzerland and Spain. Emily Sites's co-authors include Dennis Bartholomew, Alain de Bruin, Gustavo Leone, Tapan Mehta, Conxi Lázaro, Grier P. Page, Nancy Ratner, Megan A. Waldrop, Shyra J. Miller and Marco Giovannini and has published in prestigious journals such as Genes & Development, Oncogene and EMBO Molecular Medicine.

In The Last Decade

Emily Sites

8 papers receiving 259 citations

Peers

Emily Sites
Comparison fields: 5 of 45
  • Molecular Biology 129
  • Neurology 78
  • Genetics 56
  • Pulmonary and Respiratory Medicine 53
  • Oncology 52
Replace Jeff Jorgensen with:
Jeff Jorgensen United States
Angela D. Bhalla United States
Laura Baker United States
Irene Valenzuela Spain
S. Rumpler Austria
Sana Sfar Tunisia
Fergus J. Couch United States
Sissel E. Monstad Norway
Anders Valind Sweden
Pak Leng Cheong Australia
Jeff Jorgensen United States View profile →
Citations per field, relative to Emily Sites
Emily Sites · 1×
Citations per year, relative to Emily Sites
Emily Sites · 1×

Countries citing papers authored by Emily Sites

Since Specialization
Citations

This map shows the geographic impact of Emily Sites's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Sites with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Sites more than expected).

Fields of papers citing papers by Emily Sites

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Sites. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Sites. The network helps show where Emily Sites may publish in the future.

Co-authorship network of co-authors of Emily Sites

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Sites. A scholar is included among the top collaborators of Emily Sites based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Sites. Emily Sites is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
# Work Indexed citations
1 1
2 25
3 29
4 6
5 9
6 30
7 93
8 67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026